Tesamorelin 20 mg

$149.99

  • Product name: Tesamorelin
  • Labeled quantity: 20 mg
  • Presentation: One boxed 3 mL vial
  • Physical format: Lyophilized powder
  • Visit COA Results 
United States dollar ($) - USD
  • United States dollar ($) - USD
Select delivery location

Tesamorelin 20 mg | Pure Lab Peptides Supply

Description

Product Overview

Buy Tesamorelin 20 mg from Pure Lab Peptides Supply, supplied as lyophilized powder in one boxed 3 mL vial for laboratory research.

Tesamorelin is a modified analogue of growth hormone-releasing hormone (GHRH). Its reference structure contains 44 amino acids and an N-terminal trans-3-hexenoyl modification. Researchers investigate its molecular identity, structural characteristics, and relationship to other GHRH-related peptides.

This listing represents a single-compound product. It is distinct from Sermorelin and from combination products containing Tesamorelin and Ipamorelin. Before selecting a presentation, compare the labeled quantity, compound identity, and product documentation.

Product Overview Details

  • Product name: Tesamorelin
  • Labeled quantity: 20 mg
  • Presentation: One boxed 3 mL vial
  • Physical format: Lyophilized powder
  • Compound class: Modified GHRH analogue
  • Reference sequence length: 44 amino acids
  • N-terminal modification: Added trans-3-hexenoyl group
  • Product type: Single-compound listing
  • Intended application: Laboratory research
  • Documentation: Available product records and batch reports, where provided

Vial capacity clarification: The 20 mg label refers to the stated quantity of material, while 3 mL describes the vial’s capacity. It does not indicate that the vial contains 3 mL of liquid or establish a prepared concentration.

Key Product Details

Tesamorelin is structurally different from shorter GHRH-related peptides. Its 44-amino-acid reference sequence and N-terminal modification help distinguish it from Sermorelin, which corresponds to a shorter 29-amino-acid fragment of GHRH.

Pure Lab Peptides Supply also lists other Tesamorelin presentations, including 5 mg and 10 mg options. In addition, Tesamorelin + Ipamorelin is a combination product rather than a single-compound listing. Therefore, check the labeled quantity and ingredient composition of each product before comparing them.

For combination products, the total labeled quantity refers to the combined components unless the product documentation specifies otherwise. It should not automatically be interpreted as the amount of Tesamorelin alone.

Scientific Background and Analytical Research

Researchers have investigated analytical techniques for identifying GHRH-related peptides in biological samples. A published study titled Qualitative Identification of Growth Hormone-Releasing Hormones in Human Plasma by Means of Immunoaffinity Purification and LC-HRMS/MS examined antibody-based enrichment and high-resolution tandem mass spectrometry.

The research also examined differences between Tesamorelin and Sermorelin, including their structural characteristics and behavior under the specific plasma-testing conditions. These findings offer scientific context for analytical investigations. However, they do not establish the storage requirements, expiration date, or stability of the material supplied in this vial.

Certificate of Analysis and Product Documentation

Review the available COA & Documents to locate relevant product documentation and, where provided, batch-specific reports.

When evaluating a certificate of analysis (COA), distinguish among three important measurements:

  • Identity: Analytical evidence used to assess whether the tested material corresponds to the named compound.
  • Purity: The proportion of the target material reported under the stated analytical method.
  • Measured content: The quantity determined through the specified analytical test.

These measurements answer different questions. For example, a reported purity percentage does not automatically establish the total amount of material in a vial. Always review the actual report, its analytical method, and the product or batch it covers.

Packaging, Storage, and Handling

Tesamorelin 20 mg is supplied as lyophilized powder in a boxed 3 mL vial. Follow the product-specific documentation for applicable handling and storage requirements.

Additionally, do not infer a storage temperature, reconstitution procedure, or shelf life from studies that examine peptides in biological plasma. Those experiments use different conditions from the storage of a supplied research material.

Order Tesamorelin 20 mg Research Material

If you are comparing GHRH-related research materials, Tesamorelin 20 mg provides a clearly labeled, single-compound presentation for analytical consideration. Before ordering, confirm the labeled quantity, product format, compound identity, and availability of relevant documentation.

Visit Pure Lab Peptides Supply to review the product catalog and available product information.

Research-use notice: This product is intended for laboratory research only. It is not presented as a medicine, dietary supplement, or product for human or veterinary use.

0
0
Your Cart
Empty CartYour cart is emptyReturn to Shop
Secure Checkout
Fast Shipping
Easy Returns